Increased production of interferon-γ by tumour infiltrating T lymphocytes in nasopharyngeal carcinoma: Indicative of an activated status

Cancer Letters

Volumn 140, Issue 1-2, 1999, Pages 93-98

  Fai Tang, Kin ^a   Ha Chan, Soh ^a   Seng Loh, Kwok ^a   Meng Chong, Siew ^a   Wang, Deyun ^a   Hian Yeoh, Kian ^a   Hu, Huaizhong ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Interferon ; Nasopharyngeal carcinoma; T cell activation; Tumour infiltrating T cells

Indexed keywords

ANTIBODY; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; LATENT MEMBRANE PROTEIN 1;

ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR BIOPSY;

ANTIGENS, CD; CARCINOMA; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; NASOPHARYNGEAL NEOPLASMS; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES;

EID: 0032972410     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00056-7     Document Type: Article

References (17)

1. Zhu X., Kong F., Chen R., Lu W. Human leucocyte antigens-A, -B, -C, and -DR and nasopharyngeal carcinoma in northern. China. Ann. Otol. Rhinol. Laryngol. 99:1990;286-287.
2. Ooi E.E., Ren E.C., Chan S.H. Association between microsatellites within the human MHC and nasopharyngeal carcinoma. Int. J. Cancer. 74:1997;229-232.
3. Brooks L., Yao Q.Y., Rickinson A.B., Young L.S. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1. LMP1, and LMP2 transcripts, J. Virol. 66:1992;2689-2697.
4. Niedobitek G., Young L.S., Sam C.K., Brooks L., Prasad U., Rickinson A.B. Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas. Am. J. Pathol. 140:1992;879-887.
5. Khanna R., Busson P., Burrows S.R., Raffoux C., Moss D.J., Nicholls J.M., Cooper L. Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells. Cancer Res. 58:1998;310-314.
6. Agathanggelou A., Niedobitek G., Chen R.W., Nicholls J., Yin W.B., Young L.S. Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma: evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells. Am. J. Pathol. 147:1995;1152-1160.
7. Yao M., Ohshima K., Suzumiya J., Kume T., Shiroshita T.-O., Kikuchi M. Interleukin-10 expression and cytotoxic-T-cell response in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Int. J. Cancer. 72:1997;398-402.
8. Herait P., Ganem G., Lipinski M., Carlu C., Micheau C., Schwaab G., De-The G., Tursz T. Lymphocyte subsets in tumour of patients with undifferentiated nasopharyngeal carcinoma: presence of lymphocytes with the phenotype of activated T cells. Br. J. Cancer. 55:1987;135-139.
9. Zong Y.S., Lin H., Choy D.T.K., Sham J.S.T., Wei W., Chan K.H., Ng M.H. Nasopharyngeal carcinoma and lymphoinfiltration. Oncology. 48:1991;290-296.
10. de Campos-Lima P.-O., Levitsky V., Imreh M.P., Gavioli R., Masucci G. Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr Virus. J. Exp. Med. 186:1997;83-89.
11. Khanna R., Burrows S.R., Kurilla M.G., Jacob C.A., Misko I.S., Sculley I.S., Kieff E., Moss D.J. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implication for vaccine development. J. Exp. Med. 176:1992;169-176.
12. Sing A.P., Ambinder R.F., Hong D.J., Jensen M., Batten W., Petersdorf E., Greenberg P.D. Isolation of Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: implications for immune-mediated therapy of EBV+ Hodgkin's disease. Blood. 89:1997;1978-1986.
13. Ferradini L., Miescher S., Stoeck M., Busson P., Barras C., Cerf-Bensussan N., Lipinski M., von Fliedner V., Tursz T. Cytotoxic potential despite impaired activation pathways in T lymphocytes infiltrating nasopharyngeal carcinoma. Int. J. Cancer. 47:1991;362-370.
14. Eynon E.E., Parker D.C. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 175:1992;131-138.
15. Fuchs E.J., Matzinger P. cells turn off virgin but not memory T cells. Science. 258:1992;1156-1159.
16. Boss J.M. Regulation of transcription of MHC class II genes. Curr. Opin. Immunol. 9:1997;107-113.
17. Hishii M., Andrews D., Boyle L.A., Wong J.T., Pandolfi F., van den Elsen P.J., Kurnick J.T. In vivo accumulation of the same anti-melanoma T cell clone in two different metastatic sites. Proc. Nat. Acad. Sci. USA. 94:1997;1378-1383.